# Verrica Pharmaceuticals Inc.: Form 8-K, filed Jun 28, 2024

- Company: [Verrica Pharmaceuticals Inc.](/companies/vrca.md) (CIK 1660334)
- Form: 8-K
- Filed: 2024-06-28
- Accepted by EDGAR: Jun 28, 2024, 16:17 ET
- Period: 2024-06-26
- Accession: 0001193125-24-172277
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524172277/d844833d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660334/000119312524172277/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660334/000119312524172277/d844833d8k.htm

Filed Jun 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-172277. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.